Whitehawk Therapeutics Inc WHWK
$3.85
▲ +0.00%
(+$0.00)
📅 Earnings This Week
Open
$3.87
Prev Close
$3.85
Day Range
$3.75 – $3.92
52W Range
$1.57 – $5.50
Market Cap
$207.07M
Beta
0.81
EPS (TTM)
$-3.59
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2018-06-26 |
| Shares Out. | 53,780,000 |
| Website | ir.whitehawktx.com/ ↗ |
| Phone | 15513212234 |
| Employees | 23 |
| Net Income | -$22.2M |
| Free Cash Flow | -$107.8M |
| Total Assets | $127.2M |
| Total Liabilities | $11.1M |
| Equity | $116.2M |
About Whitehawk Therapeutics Inc
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.
Whitehawk Therapeutics Inc is a publicly traded company under the ticker symbol WHWK on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
13 analysts (2026-07-01)